Commentary: on Diagnostics and treatment of BRCA-associated cancers with olaparib -- expert position statement.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 309, doi. 10.5603/ocp.100207
- By:
- Publication type:
- Article
Works matching IS 24501654 AND DT 2024 AND VI 20 AND IP 4
Results: 11
1
2
Commentary: on Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer -- Polish multicenter experience.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 308, doi. 10.5603/ocp.97067
- By:
- Publication type:
- Article
3
Combination of chemotherapy and endocrine treatment in breast cancer -- is it still a taboo?
- Published in:
- Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 302, doi. 10.5603/ocp.100128
- By:
- Publication type:
- Article
4
Wise and skillful utilization of contemporary endocrine therapies for the treatment of ER+/HER2- advanced breast cancer.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 291, doi. 10.5603/ocp.97946
- By:
- Publication type:
- Article
5
Ivosidenib in the treatment of patients with IDH1 mutated cholangiocarcinoma.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 286, doi. 10.5603/ocp.97707
- By:
- Publication type:
- Article
6
Unlocking the potential: the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) as biomarkers informing immunotherapy outcomes in lung cancer patients -- single oncology center experience and literature review.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 278, doi. 10.5603/ocp.99846
- By:
- Publication type:
- Article
7
Preventing 5-fluorouracil-induced ischemic events in very high-risk cardiac patients with documented ischemic heart disease: a retrospective cohort analysis.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 270, doi. 10.5603/ocp.99748
- By:
- Publication type:
- Article
8
Encorafenib plus cetuximab in patients with BRAF<sub>V600E</sub>-mutated metastatic colorectal cancer -- Polish multicenter experience.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 264, doi. 10.5603/ocp.98519
- By:
- Publication type:
- Article
9
Interventions of Polish Emergency Medical Teams in patients with malignant tumors -- a four-year follow-up (2019-2022).
- Published in:
- Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 255, doi. 10.5603/ocp.98815
- By:
- Publication type:
- Article
10
The relationship between inflammation markers, positron emission tomography/ /computed tomography parameters and disease prognosis in advanced non-small-cell lung cancer patients.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 245, doi. 10.5603/ocp.97451
- By:
- Publication type:
- Article
11
Diagnostics and treatment of BRCA-associated cancers with olaparib -- expert position statement.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 229, doi. 10.5603/ocp.99216
- By:
- Publication type:
- Article